se of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosisSTUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 - 68Ga-DOTA-NOC/ILD01/2008

• Conditions: patients with Idiopathic pulmonary fibrosis; MedDRA version: 9.1Level: LLTClassification code 10021240Term: Idiopathic pulmonary fibrosis

• Registration Number: EUCTR2008-007168-40-IT
• Lead Sponsor: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03-09
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Diagnosis of Idiopathic Pulmonary Fibrosis (IPF, NSIP)
2.Age > 18
3.Informed consent signed
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1.Pregnancy
2.Breast feeding
3.Healthy volunteers
4.Age <18
5.Patients in emergency state
6.Individuals with reduced approval competence expressing any reluctance to participate to the study as well as those not understanding the purpose of the study
7.Informed consent not signed

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified